Ophtalmologie - Systemic adverse effects of topical ocular treatments - 06/05/08
Key points |
Systemic adverse effects of topical ocular treatments |
- Some eyedrops, gels or ointments may cause adverse effects as serious as those observed with systemic therapies.
- Because of their relatively poor penetration into eye tissue, ophthalmic drugs usually contain high concentrations of their active ingredient.
- Asking patients about these drugs to prevent interactions is useful when prescribing a new systemic treatment.
- Conversely, it is advisable to ask about ophthalmic drugs during the etiological investigation of possible iatrogenic effects.
Esquema
© 2008 Elsevier Masson SAS. Tous droits réservés.
Vol 34 - N° 8
P. 589-595 - avril 2005 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.